Cargando…
The Role of Genetic Polymorphisms in Chronic Pain Patients
It is estimated that the total annual financial cost for pain management in the U.S. exceeds 100 billion dollars. However, when indirect costs are included, such as functional disability and reduction in working hours, the cost can reach more than 300 billion dollars. In chronic pain patients, the r...
Autores principales: | Knezevic, Nebojsa Nick, Tverdohleb, Tatiana, Knezevic, Ivana, Candido, Kenneth D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032204/ https://www.ncbi.nlm.nih.gov/pubmed/29890676 http://dx.doi.org/10.3390/ijms19061707 |
Ejemplares similares
-
Do we need to establish guidelines for patients with neuromodulation implantable devices, including spinal cord stimulators undergoing nonspinal surgeries?
por: Ghaly, Ramsis F., et al.
Publicado: (2016) -
Treatment of chronic low back pain – new approaches on the horizon
por: Knezevic, Nebojsa Nick, et al.
Publicado: (2017) -
Can Implementation of Genetics and Pharmacogenomics Improve Treatment of Chronic Low Back Pain?
por: Suntsov, Vladislav, et al.
Publicado: (2020) -
Lumbar epidural analgesia for labor in a parturient with a history of surgery for lumbar intradural ependymoma: Literature review and case presentation
por: Ghaly, Ramsis F., et al.
Publicado: (2018) -
Management of parturients in active labor with Arnold Chiari malformation, tonsillar herniation, and syringomyelia
por: Ghaly, Ramsis F., et al.
Publicado: (2017)